Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
Bortezomib is a promising anticancer drug targeting the proteasome.
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition
Nº de artículo: 19018753

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition

Nº de artículo: 19018753

DOP 7586

Price Details

Excluding Shipping & Custom charges ( Shipping and custom charges will be calculated on checkout )

*All items will import from Estados Unidos

En stock
Estados Unidos Importado de la tienda USA

QTY:

Haz tu pedido ahora y recíbelo por ahí Sunday, Octubre 18
Our Top Logistics Partners
  • fedex
  • dhl
Bortezomib is a promising anticancer drug targeting the proteasome.
Garantía U-Care:
Ninguno
Selecciona un plan
fast shipping

Fast
Shipping

free return

Free
Return*

secure packaging

Secure Packaging

100% original products

100% Original Products

pci-dss

PCI DSS Compliance

iso certified

ISO 27001 Certified


paypal payment
visa payment
mastercard payment

What Stands Out

Comprehensive Overview
This edition provides an extensive examination of Bortezomib, detailing its development, mechanism, and therapeutic impact on multiple myeloma, making it an essential resource for healthcare professionals and researchers.
Evidence-Based Insights
Incorporates cutting-edge research and clinical trials, offering evidence-based insights that enhance understanding of Bortezomib’s efficacy and its role in treatment regimens, supporting informed decision-making in patient care.
Updated Protocols
Includes the latest treatment protocols and guidelines for using Bortezomib, ensuring that practitioners have current, best-practice information for integrating this drug into modern multiple myeloma therapy.

Detalles de producto

Discover Bortezomib, a breakthrough drug for Multiple Myeloma treatment. Order now from Ubuy Dominican Republic and avail global delivery. Shop now!
  • Bortezomib is a promising anticancer drug targeting the proteasome, inducing cell stress and apoptosis in cancer cells.
  • The drug is valuable for researchers and clinicians in oncology and pharmacology, working in academia or the pharmaceutical industry.
  • Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells.
  • Plasma cells, responsible for antibody production, are a crucial part of the immune system.
  • Proteasome inhibition by Bortezomib may prevent the degradation of pro-apoptotic factors, allowing activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways.
  • The monograph on bortezomib serves as a valuable source of information for both researchers and clinicians in the field of oncology and pharmacology.
Publisher Springer
Publication date November 11, 2010
Edition 2011th
Language English
Print length 188 pages
ISBN-10 3764389478
ISBN-13 978-3764389475
Item Weight 15.2 ounces (430.92 grams)
Dimensions 6.2 x 0.6 x 9.4 inches (15.7 x 1.5 x 23.9 cm)
Part of series Milestones in Drug Therapy

Who Should Buy?

Suitable For
  • Healthcare Professionals

    Oncologists and healthcare professionals seeking comprehensive information on Bortezomib and its efficacy for treating multiple myeloma.

  • Medical Students

    Students studying oncology or drug therapy will benefit from detailed insights into Bortezomib's role in treatment protocols.

  • Patients and Caregivers

    Individuals affected by multiple myeloma who want to understand treatment options and experiences with Bortezomib.

Not Suitable For
  • General Public

    Individuals not involved in healthcare may find the technical content challenging and less relevant for general health understanding.

DESCRIPCIÓN DEL PRODUCTO

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy) 2011th Edition

¿Tienes alguna consulta? Chatea con nosotros

Preguntas y respuestas de los clientes

  • Pregunta: What is Bortezomib and how does it work in treating Multiple Myeloma?

    Respuesta: Bortezomib is a proteasome inhibitor used as a chemotherapy drug in the treatment of Multiple Myeloma. It works by blocking the proteasome's function, leading to the accumulation of proteins that promote apoptosis, or programmed cell death, in cancer cells. This helps to hinder the growth of malignant plasma cells. In practice, patients may experience a reduction in tumor size and improvement in blood cell counts, making Bortezomib a pivotal part of combination therapies.
  • Pregunta: What are the side effects of Bortezomib?

    Respuesta: Common side effects of Bortezomib can include nausea, fatigue, nerve damage, and low blood cell counts. Understanding these potential effects allows patients and caregivers to be proactive in managing symptoms and coordinating care. For instance, if a patient experiences severe fatigue, adjustments to their daily schedule and lifestyle might be warranted to ensure they maintain a good quality of life during treatment.
  • Pregunta: How is Bortezomib administered to patients?

    Respuesta: Bortezomib can be administered via injection either subcutaneously or intravenously. The route and method depend on the specific treatment plan and the doctor's guidance. Patients might find subcutaneous injections more convenient as they can be less painful and simpler, helping to enhance compliance and ensuring the effectiveness of the therapy.
  • Pregunta: What is the significance of the 2011 edition in drug therapy milestones for Bortezomib?

    Respuesta: The 2011 edition highlights pivotal studies and advancements in the use of Bortezomib over the years. It showcases critical milestones, including its approval and combination with other therapies, which have shaped current treatment protocols. This edition serves not just as a historical reference but also provides insights for clinicians in optimizing treatment strategies for more effective outcomes.
  • Pregunta: Can Bortezomib be used in combination with other treatments?

    Respuesta: Yes, Bortezomib is often used in combination with other drugs such as dexamethasone and lenalidomide to enhance its effectiveness. This multi-drug approach is crucial as it attacks cancer cells from various angles, potentially leading to better remission rates. Combining therapies allows for more tailored treatment plans based on individual responses, expanding options for patients facing Multiple Myeloma.
  • Pregunta: What should I know about monitoring while on Bortezomib therapy?

    Respuesta: Monitoring is essential during Bortezomib therapy due to its effects on blood counts and nerve health. Regular blood tests will help track changes and guide necessary adjustments in treatment. Additionally, patients should be vigilant for any new or worsening symptoms, enabling prompt medical response and management which is crucial for ensuring safe and effective treatment.
  • Pregunta: What lifestyle changes may support patients undergoing Bortezomib treatment?

    Respuesta: Patients are encouraged to maintain a balanced diet, stay hydrated, and engage in light physical activity as tolerated, all of which contribute to overall health during treatment. Stress management practices such as mindfulness and yoga can also be beneficial. These lifestyle choices help bolster the body’s response to treatment and enhance the overall well-being of individuals fighting Multiple Myeloma.
  • Pregunta: Is there a specific diet recommended for patients on Bortezomib?

    Respuesta: While there isn't a one-size-fits-all diet, a balanced intake rich in fruits, vegetables, lean proteins, and whole grains is generally recommended. Adequate nutrition can support immune function and help manage side effects such as nausea. For instance, consuming small, frequent meals can alleviate gastrointestinal discomfort, making it a practical strategy for those undergoing therapy.
  • Pregunta: Are there any support resources for patients receiving Bortezomib?

    Respuesta: Several organizations provide support for patients undergoing Multiple Myeloma treatment with resources such as educational materials, counseling, and community support groups. Connecting with such resources can offer emotional support and useful information, aiding patients in navigating their journey through treatment more effectively.
  • Pregunta: Where can I buy Bortezomib in the Treatment of Multiple Myeloma Milestones in Drug Therapy 2011th Edition?

    Respuesta: You can purchase the 2011th Edition of Bortezomib in the Treatment of Multiple Myeloma Milestones in Drug Therapy through Ubuy. Ubuy offers a user-friendly platform where you can find this specific edition, ensuring that you receive a reliable source for your medical literature needs, ultimately aiding in informed decisions about treatment.

Cell Biology Editorial Review

No se encontraron reseñas editoriales

Customer Reviews & Ratings

1 valoraciones de los clientes
  • 5 estrella
    100%
  • 4 estrella
    0%
  • 3 estrella
    0%
  • 2 estrella
    0%
  • 1 estrella
    0%

Revisar este producto

Comparte tus ideas con otros clientes

ventajas

  • Effective treatment option
  • Improves patient outcomes
  • Wide range of research support
  • Well-tolerated by many patients
  • Comprehensive information provided

Contras

  • Some may experience mild side effects.

Platform Trust & Buyer Confidence

trustpilot logo
4.2/5 9477 reseñas
Read reviews
JK
Jasmin
Verified buyer

“Great products and very good service: very easy and very fast international delivery.”

9 September 2026 · via Trustpilot
AG
Anke
Verified buyer

“Wonderful online shopping experience, smooth transaction from the start. Payment method works conveniently and delivery is unexpectedly fast and reliable. You go the extra mile for service. What makes this even more amazing, you deliver to Namibia. I will remain a happy Ubuy customer and will increase my purchases for sure! Thank you!”

10 September 2026 · via Trustpilot
H
Hazel
Verified buyer

“Very easy to find the products what you need, and so fast delivery, that’s why I highly recommended to others costumers to used ubuy.”

10 September 2026 · via Trustpilot
O
Opaleye
Verified buyer

“I received exactly what I ordered I was skeptical about your site because that was my first time to order. But the order came timely and neatly packaged. I was not disappointed. Thank you.”

11 September 2026 · via Trustpilot
AC
Adele
Verified buyer

“Easy to find and order what you want on the website. Delivery is quick to the UK”

8 September 2026 · via Trustpilot
Pago seguro Global Delivery Easy Returns Genuine Products

Product Price History

Información importante

  • Limitaciones: Para los productos enviados al extranjero, ten en cuenta que cualquier garantía del fabricante puede no ser válida; las opciones de servicio del fabricante pueden no estar disponibles; los manuales del producto, las instrucciones y las advertencias de seguridad pueden no estar en los idiomas del país de destino; los productos (y los materiales que los acompañan) pueden no estar diseñados de acuerdo con las normas, especificaciones y requisitos de etiquetado del país de destino; y los productos pueden no ajustarse al voltaje del país de destino y a otras normas eléctricas (lo que requiere el uso de un adaptador o convertidor, si procede). El destinatario es responsable de asegurarse de que el producto puede ser importado legalmente al país de destino. Cuando hagas un pedido a Ubuy o a sus filiales, el destinatario es el importador registrado y debe cumplir todas las leyes y normativas del país de destino.
  • No todos los productos que aparecen en Ubuy están a la venta, ya que Ubuy es un motor de búsqueda a nivel mundial. Los productos están sujetos a las normas de exportación/comercio.